Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
20,788,527
-
Total 13F shares
-
114,171,023
-
Share change
-
-1,616,245
-
Total reported value
-
$1,463,210,133
-
Put/Call ratio
-
21%
-
Price per share
-
$12.82
-
Number of holders
-
140
-
Value change
-
-$20,565,583
-
Number of buys
-
60
-
Number of sells
-
73
Institutional Holders of Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) as of Q2 2014
As of 30 Jun 2014,
Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) was held by
140 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
114,171,023 shares.
The largest 10 holders included
OPPENHEIMER FUNDS INC, PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, FEDERATED INVESTORS INC /PA/, FIRST TRUST ADVISORS LP, State Street Corp, BlackRock Fund Advisors, JPMORGAN CHASE & CO, GRANAHAN INVESTMENT MANAGEMENT INC/MA, and Bank of New York Mellon Corp.
This page lists
140
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.